Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CERO

CERo Therapeutics (CERO)

CERo Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CERO
DateTimeSourceHeadlineSymbolCompany
09/25/20249:17AMGlobeNewswire Inc.CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236NASDAQ:CEROCERo Therapeutics Holdings Inc
07/08/20248:00AMGlobeNewswire Inc.CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024NASDAQ:CEROCERo Therapeutics Holdings Inc
06/13/20248:15AMGlobeNewswire Inc.CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236NASDAQ:CEROCERo Therapeutics Holdings Inc
06/06/20248:00AMGlobeNewswire Inc.CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236NASDAQ:CEROCERo Therapeutics Holdings Inc
05/15/20248:00AMGlobeNewswire Inc.CERo Therapeutics, Inc. Provides Corporate Update for ShareholdersNASDAQ:CEROCERo Therapeutics Holdings Inc
04/30/20249:00AMGlobeNewswire Inc.CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing AttributesNASDAQ:CEROCERo Therapeutics Holdings Inc
03/07/20247:00AMBusiness WireCERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML PatientsNASDAQ:CEROCERo Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERO